Destiny Pharma Share Discussion Threads

[sev22] 12/1/2022 10:25

Q&A with Judith MacKenzie, Partner and Head of Downing Fund Managers:

Exciting early-stage healthcare opportunities - highlights Destiny Pharma at the 40 minutes stage of the discussion.

[supracat] 05/1/2022 18:55

I think you are right about Feb for NT l, however I do think DP will announce a Nasdaq listing to help tap into a wider market of investors to help raise funds for XF should a good partnering deal not materialise for that drug.

[ttlance] 05/1/2022 17:06

Based on interviews to date with the management I reckon there's been a lot more partnering interest in NTCD-M3 and not so much for XF-73, hence the delay. The expectation was partnering to be announced in Q4. I hope I'm wrong as I am fully invested here but I'm going for a partnering agreement being announced in late Feb, coupled with an equity raise for XF-73.

[sev22] 05/1/2022 15:43

The Company are showcasing themselves next week:

[sicilian_kan] 05/1/2022 11:59

In my limited experience, it takes around 9 months to partner. We are now in my view in the window this month / quarter where a partnership announcement would be expected.

[timbo003] 21/12/2021 08:05

Summit's ridinilazole study misses primary endpoint in C.Diff study (announced yesterday)

[sicilian_kan] 10/12/2021 13:42

Agreed, excellent presentation. Have to get past his dry personality, but what was said was very encouraging and looks like Q1 could be very busy on a number of fronts.

[sev22] 10/12/2021 09:30

Proactive ONE2ONE Virtual Investor Forum - Thursday December 9th 2021 - YouTube:



Neil Clark of DEST was on first and it was a very good presentation.

[sev22] 09/12/2021 15:50

Neil Clark (CEO) is presenting on the Proactive One2One Investor Forum tonight. It commences at 6pm and registration is free.

[sev22] 03/12/2021 10:25

You can currently buy or sell at £1.12, which seems odd. Do the market makers require stock in advance of long awaited news?

[supracat] 30/11/2021 18:43

Agree. Always expected a deal on at least one of the opportunities, pre xMas. Perhaps someone has wind of something which is imminent.

[sev22] 30/11/2021 14:27

According to my level 2, there's 3 x 65,000 blocks of shares just been reported. The total volume traded on the day is up to 230,000. Someone can see clear value here.

I wonder if a positive update is imminent and there's been a leak...

[t0pgrader] 30/11/2021 01:21

Well done. And now we wait.....

[t0pgrader] 29/11/2021 09:43

The £18,000 top-up buys this am are mine.

[gbjbaanb] 26/11/2021 23:25

The drop is because of the new variant (which might not be new if documents talking about it in July are true) which has take the entire market. Expect more, possibly the rich are looking to buy back in shortly and make a killing, just like March last year.

[sev22] 26/11/2021 18:02

Really surprised someone let those thieving market makers take 7000 shares off them for £1.06 just before the bell.

Down 8% on less than 27000 shares traded, it's outrageous really.

Todays drop has followed the whole market down because of covid jitters.

Let's not lose sight of why DEST has the potential to be an exceptional investment.

We must be due some positive news in the coming weeks.

Edit - there's a delayed trade for 15000 shares, not sure if its a buy or sell.

[barony] 26/11/2021 17:47

Huge drop for no apparent reason. Puzzling.

[sev22] 26/11/2021 11:49

As Professor Gerding acknowledges towards the end of the interview, Destiny Pharma with its two high quality late-stage clinical assets, is well and truly under the radar and there is a huge discrepancy in valuation terms when compared with its American peers.

[edmonda] 26/11/2021 09:31

For those who enjoy hearing from a world leading expert, a fascinating interview with Professor Dale Gerding on C difficile and the treatment potential of Destiny's M3 - you can watch it here:

[supracat] 24/11/2021 20:37

Very positive.